We are live on
!
Find out more
AC
AltraVue Capital Portfolio holdings
AUM
$1.16B
1-Year Est. Return
46.45%
This Fund
S&P 500
This Quarter
Est. Return
-2.64%
1 Year Est. Return
+46.45%
3 Year Est. Return
+174.8%
5 Year Est. Return
+275.78%
10 Year Est. Return
–
AUM
$997M
AUM Growth
-$204M
(-17%)
Cap. Flow
-$148M
Cap. Flow
% of AUM
-14.81%
Top 10 Holdings %
Top 10 Hldgs %
62.26%
Holding
28
New
1
Increased
6
Reduced
17
Closed
1
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
TripAdvisor
TRIP
|
+$12.2M |
| 2 |
UnitedHealth
UNH
|
+$7.09M |
| 3 |
i3 Verticals
IIIV
|
+$5M |
| 4 |
Triumph Financial Inc
TFIN
|
+$3.85M |
| 5 |
ePlus
PLUS
|
+$2.24M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Palantir
PLTR
|
+$88.5M |
| 2 |
CDMO
Avid Bioservices, Inc. Common Stock
CDMO
|
+$46.9M |
| 3 |
IES Holdings
IESC
|
+$8.82M |
| 4 |
Argan
AGX
|
+$4.17M |
| 5 |
StoneX
SNEX
|
+$3.95M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 24.27% |
| 2 | Technology | 20.73% |
| 3 | Industrials | 19.87% |
| 4 | Consumer Discretionary | 13.68% |
| 5 | Healthcare | 8.38% |
Similar funds
BI
FP
SFG
SCP
GAB
FFP
MI
AMI
AltraVue Capital's Q1 2025 Portfolio in Review
As of Q1 2025, AltraVue Capital held 28 positions worth $997M, down 17% from $1.2B the previous quarter. Its ten largest holdings account for 62% of the portfolio.
AltraVue Capital withdrew a net $148M in Q1 2025, closing 1 position and reducing 17 holdings. Its most notable exit was Avid Bioservices, Inc. Common Stock, an estimated $46.9M position sold in full.
By sector, the portfolio is most concentrated in Financials at 24% of assets, up from 22% a quarter earlier, followed by Technology and Industrials.
Against the trend, AltraVue Capital opened a new position in TripAdvisor worth $11M.
- AltraVue Capital's largest Q1 2025 buy was TripAdvisor: 778,240 shares worth $11M.
- AltraVue Capital added most to UnitedHealth in Q1 2025, an estimated $7.09M increase.
- AltraVue Capital's biggest Q1 2025 reduction was Palantir, cutting an estimated $88.5M.
- AltraVue Capital fully exited Avid Bioservices, Inc. Common Stock in Q1 2025, selling an estimated $46.9M.
- AltraVue Capital's ten largest holdings make up 62% of its $997M portfolio in Q1 2025.
- AltraVue Capital opened 1 new position and closed 1 in Q1 2025.
- AltraVue Capital's portfolio value fell 17% quarter-over-quarter to $997M.
Based on AltraVue Capital's 13F filing for Q1 2025, filed 13 May 2025.